A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$56.50
0.00%
(0.00) 1H
14 Okt, 4:56:00 PTG GMT-3 · BRL
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk A1LN34...
Buka
R$56.46
Tinggi
R$56.50
Rendah
R$56.28
Permodalan Pasaran
30.04B
Purata volum
495.00
Volum
195.00
tgi 52 mgu
R$132.40
rdh 52 mgu
R$50.25
Syer tertunggak
133.81J
Bilangan pekerja
2K
Buka
R$56.46
Tinggi
R$56.50
Rendah
R$56.28
Permodalan Pasaran
30.04B
Purata volum
495.00
Volum
195.00
tgi 52 mgu
R$132.40
rdh 52 mgu
R$50.25
Syer tertunggak
133.81J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Yahoo Finance
·
9 jam lalu
Alnylam Pharmaceuticals (ALNY) vs. IONS and ARWR: Can Pipeline Growth Restore Confidence After the Guidance Cut?
BioSpace
·
21 jam lalu
Alnylam bulls and bears fight it out after business-shaking guidance cut
The Globe and Mail
·
2 minggu lalu
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Perihal Alnylam Pharmaceuticals Inc Bdr